10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0000930413-11-005153`
Period End Date	20110630
Filing Date	20110805
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	enzn-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 116 Cash Flow Statement 68

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on Property and equipment (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$38.29M	USD	Point-in-time
Accumulated depreciation on Property and equipment (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$39.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Preferred stock shares par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$50.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$399.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time
Preferred stock shares par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$31.17M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$41.08M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.19M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$363.14M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$434.62M	USD	Point-in-time
Common stock, shares par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $39,983 at June 30, 2011 and $38,286 at December 31, 2010	`PropertyPlantAndEquipmentNet`	$19.48M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $39,983 at June 30, 2011 and $38,286 at December 31, 2010	`PropertyPlantAndEquipmentNet`	$21.57M	USD	Point-in-time
Common stock, shares par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$3.32M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$31.39M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$759.00K	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	58.82M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.27M	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	50.63M	shares	Point-in-time
Total assets	`Assets`	$386.70M	USD	Point-in-time
Total assets	`Assets`	$488.86M	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	50.63M	shares	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	58.82M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.19M	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$11.05M	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$14.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.48M	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$134.50M	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$134.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.27M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$157.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$151.25M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 50,631,943 shares at June 30, 2011 and 58,817,561 shares at December 31, 2010	`CommonStockValue`	$588.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 50,631,943 shares at June 30, 2011 and 58,817,561 shares at December 31, 2010	`CommonStockValue`	$506.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$365.33M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$454.66M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$556.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$914.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-130.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-124.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$331.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$235.45M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$386.70M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$488.86M	USD	Point-in-time

Income Statement 116 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$9.17M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$10.59M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$23.49M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$20.93M	USD	2 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	$5.00M	USD	2 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	$40.90M	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$2.60M	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$231.00K	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$5.21M	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$1.32M	USD	2 Qtrs
Miscellaneous revenue	`OtherSalesRevenueNet`	$2.28M	USD	2 Qtrs
Miscellaneous revenue	`OtherSalesRevenueNet`	$362.00K	USD	2 Qtrs
Miscellaneous revenue	`OtherSalesRevenueNet`	$527.00K	USD	1 Quarter
Miscellaneous revenue	`OtherSalesRevenueNet`	$196.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$9.60M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$27.62M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$13.72M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$71.88M	USD	2 Qtrs
Research and development pipeline	`ResearchAndDevelopmentExpense`	$10.06M	USD	1 Quarter
Research and development pipeline	`ResearchAndDevelopmentExpense`	$10.13M	USD	1 Quarter
Research and development pipeline	`ResearchAndDevelopmentExpense`	$21.65M	USD	2 Qtrs
Research and development pipeline	`ResearchAndDevelopmentExpense`	$20.61M	USD	2 Qtrs
Research and development specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$184.00K	USD	1 Quarter
Research and development specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$4.82M	USD	2 Qtrs
Research and development specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$831.00K	USD	2 Qtrs
Research and development specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$1.76M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$5.77M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$9.71M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$15.61M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$4.63M	USD	1 Quarter
General and administrative contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$54.00K	USD	1 Quarter
General and administrative contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$112.00K	USD	2 Qtrs
General and administrative contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$1.82M	USD	2 Qtrs
General and administrative contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$421.00K	USD	1 Quarter
Restructuring charge	`RestructuringCharges`	$1.03M	USD	2 Qtrs
Restructuring charge	`RestructuringCharges`	$674.00K	USD	1 Quarter
Restructuring charge	`RestructuringCharges`	$710.00K	USD	1 Quarter
Restructuring charge	`RestructuringCharges`	$10.60M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$18.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$54.49M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$32.30M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$15.60M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-4.68M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-6.00M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$17.38M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-5.08M	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$845.00K	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$811.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$1.78M	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$386.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.48M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.16M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.48M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.96M	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-30.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-31.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$159.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$31.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpenseIncludingInterestExpense`	$-1.96M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpenseIncludingInterestExpense`	$-2.40M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpenseIncludingInterestExpense`	$-700.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpenseIncludingInterestExpense`	$-1.06M	USD	1 Quarter
(Loss) income from continuing operations, before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.78M	USD	1 Quarter
(Loss) income from continuing operations, before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-7.06M	USD	1 Quarter
(Loss) income from continuing operations, before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.98M	USD	2 Qtrs
(Loss) income from continuing operations, before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-6.63M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$5.00K	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-205.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$5.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-205.00K	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-7.07M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-5.57M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$15.18M	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-6.64M	USD	2 Qtrs
(Loss) income and gain from discontinued operations, net of income tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	2 Qtrs
(Loss) income and gain from discontinued operations, net of income tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-51.00K	USD	1 Quarter
(Loss) income and gain from discontinued operations, net of income tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$179.00M	USD	2 Qtrs
(Loss) income and gain from discontinued operations, net of income tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$194.19M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-6.64M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-7.07M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-5.62M	USD	1 Quarter
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.12	USD	2 Qtrs
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.09	USD	1 Quarter
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.27	USD	2 Qtrs
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.13	USD	1 Quarter
Diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.09	USD	1 Quarter
Diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.23	USD	2 Qtrs
Diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.12	USD	2 Qtrs
Diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.13	USD	1 Quarter
Basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$3.16	USD	2 Qtrs
Basic (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	2 Qtrs
Diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$2.38	USD	2 Qtrs
Diluted (in Dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.12	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$3.43	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.12	USD	2 Qtrs
Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$2.61	USD	2 Qtrs
Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Weighted average shares basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	53.05M	shares	1 Quarter
Weighted average shares basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.64M	shares	2 Qtrs
Weighted average shares basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.37M	shares	2 Qtrs
Weighted average shares basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	60.85M	shares	1 Quarter
Weighted average shares - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	53.05M	shares	1 Quarter
Weighted average shares - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	60.85M	shares	1 Quarter
Weighted average shares - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.37M	shares	2 Qtrs
Weighted average shares - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	75.21M	shares	2 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$194.19M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-6.64M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-7.07M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-5.62M	USD	1 Quarter
Income and gain from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	2 Qtrs
Income and gain from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-51.00K	USD	1 Quarter
Income and gain from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$179.00M	USD	2 Qtrs
Income and gain from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-7.07M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-5.57M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$15.18M	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperations`	$-6.64M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$2.56M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$2.86M	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$269.00K	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$1.85M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$4.74M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.97M	USD	2 Qtrs
Write-down of property and equipment	`TangibleAssetImpairmentCharges`	$895.00K	USD	2 Qtrs
Write-down of property and equipment	`TangibleAssetImpairmentCharges`	-	USD	2 Qtrs
Loss on disposal of fixed assets	`GainLossOnDispositionOfProperty`	-	USD	2 Qtrs
Loss on disposal of fixed assets	`GainLossOnDispositionOfProperty`	$-61.00K	USD	2 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$128.00K	USD	2 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$80.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-14.62M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$3.13M	USD	2 Qtrs
Net cash (used in) provided by operating activities of continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.99M	USD	2 Qtrs
Net cash (used in) provided by operating activities of continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$40.02M	USD	2 Qtrs
Net cash provided by operating activities of discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by operating activities of discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$436.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$40.46M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.99M	USD	2 Qtrs
Proceeds from sale of business, net	`ProceedsFromDivestitureOfBusinesses`	$262.61M	USD	2 Qtrs
Proceeds from sale of business, net	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$530.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$397.00K	USD	2 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$44.03M	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.04M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$759.00K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.54M	USD	2 Qtrs
Net cash provided by investing activities of continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$16.76M	USD	2 Qtrs
Net cash provided by investing activities of continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$304.70M	USD	2 Qtrs
Net cash used in investing activities of discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash used in investing activities of discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-105.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$16.76M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$304.60M	USD	2 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$96.05M	USD	2 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$18.14M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$5.56M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$25.29M	USD	2 Qtrs
Withholding taxes share-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$894.00K	USD	2 Qtrs
Withholding taxes share-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.33M	USD	2 Qtrs
Redemptions from employee stock purchase plan, net	`ProceedsFromStockPlans`	$-138.00K	USD	2 Qtrs
Redemptions from employee stock purchase plan, net	`ProceedsFromStockPlans`	$-42.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.69M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-91.43M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$348.74M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-79.66M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$50.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$399.18M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$399.18M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.